학술논문
A43 - Aflibercept in combination with FOLFIRI for the 2nd-line treatment of patients with metastatic colorectal cancer (MCRC): safety data from a single institute experience
Document Type
Article
Author
Source
In Annals of Oncology October 2017 28 Supplement 6:vi15-vi15
Subject
Language
ISSN
0923-7534